Nabil Kerrouche
Nestlé Skin Health Galderma R&D
Biot, France
Biot, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Retrospective Assessment of Social Rejection Related to Atopic Dermatitis During Childhood and Adolescence: The Scars of Life-Eczema Study.
Journal: International journal of dermatology
Published: January 16, 2026
Impact of atopic dermatitis on education and career choices: the Scars of Life international study.
Journal: The Journal of investigative dermatology
Published: January 06, 2026
The long-term impact of childhood and adolescent atopic dermatitis on physical and psychosocial wellbeing: Scars of Life project.
Journal: Clinical and experimental dermatology
Published: January 04, 2026
Atopic dermatitis beyond the skin: Characterizing skin pain in the "Scars of Life" study.
Journal: JAAD international
Published: December 16, 2025
More than a symptom: itch as an independent clinical contributor in atopic dermatitis - a global-scale study on 15,223 patients.
Journal: The British journal of dermatology
Published: June 06, 2025
More than a symptom: itch as an independent clinical contributor in atopic dermatitis: a global-scale study on 15 223 patients.
Journal: The British journal of dermatology
Published: June 06, 2025
Suicidal ideation in patients with atopic dermatitis: A case-control study on 23,191 adults.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 06, 2025
International insights into bullying in patients with atopic dermatitis: Global trends and key predictors.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 20, 2025
Atopic dermatitis starting in childhood has a stronger impact on adults: results from the 'Scars of Life' international project in 27 countries.
Journal: The British journal of dermatology
Published: December 04, 2024
Patient-Reported Outcomes in Acne Patients With Skin of Color Using Adapalene 0.3%-Benzoyl Peroxide 2.5%: A Prospective Real-World Study
Journal: Journal of drugs in dermatology : JDD
Published: June 29, 2019
Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne.
Journal: American journal of clinical dermatology
Published: June 19, 2019
A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea.
Journal: Journal of the American Academy of Dermatology
Published: March 27, 2019
Last Updated: 09/26/2026